Swiss drugmaker Vifor had bid interest but talks halted

Swiss drugmaker Vifor had bid interest but talks halted

Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said. The financial investors behind the initial approach suspended the...